SERINA THERAPEUTICS INC. (SER) Forecast, Price Target & Analyst Ratings
NYSEARCA:SER • US81751A1088
1.53 USD
-0.04 (-2.55%)
Last: Mar 6, 2026, 08:04 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SERINA THERAPEUTICS INC. (SER).
Forecast Snapshot
Consensus Price Target
$13.26
+ 766.67% Upside
Next Earnings Forecast
Release DateMar 23, 2026
PeriodQ1 / 2026
EPS Estimate-$0.45
Revenue Estimate
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$13.26
Upside
+ 766.67%
From current price of $1.53 to mean target of $13.26, Based on 6 analyst forecasts
Low
$11.11
Median
$13.26
High
$15.75
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 analysts have analysed SER and the average price target is 13.26 USD. This implies a price increase of 766.67% is expected in the next year compared to the current price of 1.53.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
SER was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SER.
In the previous month the buy percentage consensus was at a similar level.
SER was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-14 | HC Wainwright & Co. | Initiate | Buy |
| 2025-03-11 | Jones Trading | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 23, 2026
PeriodQ1 / 2026
EPS Estimate-$0.45
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q8.28%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
SER is expected to report earnings on 3/23/2026. The consensus EPS estimate for the next earnings is -0.45 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30K -78.57% | 142K 373.33% | 56K -60.56% | 131.3K 134.46% | -100.00% | 27.773M | |||||||
| EBITDA YoY % growth | -6.85M 13.40% | -9.829M -43.49% | -16.854M -71.47% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.98M 13.18% | -9.96M -42.69% | -17.048M -71.16% | -23.351M -36.97% | -30.458M -30.43% | -34.066M -11.85% | -42.567M -24.95% | -49.497M -16.28% | -56.574M -14.30% | -57.814M -2.19% | -72.805M -25.93% | -59.117M 18.80% | |
| Operating Margin | -23,266.67% | -7,014.08% | -30,442.86% | -17,784.62% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -212.86% | |
| EPS YoY % growth | N/A | N/A | N/A | -2.03 | -1.82 10.20% | -1.41 22.44% | -1.21 14.29% | -1.26 -4.17% | -1.14 9.60% | -1.16 -1.77% | -1.43 -23.48% | -1.08 24.65% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.45 8.28% | -0.46 30.37% | -0.46 8.90% | -0.45 -66.46% |
| Revenue Q2Q % growth | -100.00% | 100.00% | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.394M -26.22% | -7.627M -37.04% | -7.74M -38.87% | -7.856M -29.61% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
2.15%
EPS Next 5 Year
3.12%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SERINA THERAPEUTICS INC. / SER Forecast FAQ
Can you provide the average price target for SERINA THERAPEUTICS INC. stock?
6 analysts have analysed SER and the average price target is 13.26 USD. This implies a price increase of 766.67% is expected in the next year compared to the current price of 1.53.
Can you provide the upcoming earnings date for SERINA THERAPEUTICS INC.?
SERINA THERAPEUTICS INC. (SER) will report earnings on 2026-03-23.
What are the consensus estimates for SERINA THERAPEUTICS INC. (SER) next earnings?
The consensus EPS estimate for the next earnings of SERINA THERAPEUTICS INC. (SER) is -0.45 USD and the consensus revenue estimate is 0 USD.
Can you provide the analyst count for SERINA THERAPEUTICS INC. stock?
The number of analysts covering SERINA THERAPEUTICS INC. (SER) is 6.